Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your blood pressure in the arteries of your lungs (measured during a heart procedure) must be above a certain level at rest (confirm with trial site)
- The resistance to blood flow through your lung arteries must be at or above a certain level at rest (confirm with trial site)
- The pressure in a specific part of your heart's blood vessels must meet certain levels, either at rest or when your legs are raised (confirm with trial site)
- You have moderate to moderately severe heart or breathing symptoms that affect your daily activity (known as NYHA Class II or III)
- Your kidneys must be working well enough to filter at least 25 ml of blood per minute
Who may not be able to join:
- You are not willing to give consent to participate or are unable to attend follow-up appointments
- Your doctors estimate you have less than 2 years to live
- You are unable to take two types of blood-thinning or anti-clotting medications, or you have an allergy or sensitivity to aspirin or clopidogrel
- You are unable to undergo a right heart catheterization (a procedure to measure pressures inside the heart)
- You have severe leaking in your aortic, mitral, or pulmonary heart valves
- You have a blood clot in any of the lung arteries that may be involved in the procedure
- You currently have an infection anywhere in your body, or a skin infection or rash at the area where the procedure would be performed
- You have had a heart device implanted (such as a pacemaker, defibrillator, or CRT device) or another heart procedure in the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julie Etheridge, Gradient
Phone: +49 16094434355
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Device related serious adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.